Continuous replication of human immunodeficiency virus type I (HIV-1) requires balanced expression of spliced and nonspliced mRNAs in the cytoplasm. This process is regulated post-transcriptionally by the viral-encoded Rev protein. An important prerequisite for Rev responsiveness is the presence of weak splice sites in the viral mRNA. We have investigated the splicing of the second intron of the HIV-1 Tat/Rev transcript in vitro and show that the 3`-splice site region is responsible for the inefficient splicing of the HIV-1 transcript. In contrast, the HIV-1 5`-splice site is highly functional in combination with a heterologous 3`-splice site. Incubation of the HIV-1 transcript in nuclear extract leads to a rapid accumulation of 50 S nonproductive pre-spliceosome complexes. These complexes contain mainly U1 and U2 small nuclear ribonucleoproteins and are formed independently of the presence of the downstream 3`-splice site. The HIV-1 transcripts, which do proceed through the first splicing step, utilize primarily a uridine as the branch acceptor nucleotide. Sequence comparison with other HIV-1 introns suggests that nucleotides other than adenosines are commonly used as branch points in these viruses.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. E. M. Abbink and B. Berkhout RNA Structure Modulates Splicing Efficiency at the Human Immunodeficiency Virus Type 1 Major Splice Donor J. Virol., March 15, 2008; 82(6): 3090 - 3098. [Abstract] [Full Text] [PDF]

				H. Hallay, N. Locker, L. Ayadi, D. Ropers, E. Guittet, and C. Branlant Biochemical and NMR Study on the Competition between Proteins SC35, SRp40, and Heterogeneous Nuclear Ribonucleoprotein A1 at the HIV-1 Tat Exon 2 Splicing Site J. Biol. Chem., December 1, 2006; 281(48): 37159 - 37174. [Abstract] [Full Text] [PDF]

				H. Kim and J. Yin Robust Growth of Human Immunodeficiency Virus Type 1 (HIV-1) Biophys. J., October 1, 2005; 89(4): 2210 - 2221. [Abstract] [Full Text] [PDF]

				J. Bohne, H. Wodrich, and H.-G. Kräusslich Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end Nucleic Acids Res., February 8, 2005; 33(3): 825 - 837. [Abstract] [Full Text] [PDF]

				D. Ropers, L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant, and J. Stevenin Differential Effects of the SR Proteins 9G8, SC35, ASF/SF2, and SRp40 on the Utilization of the A1 to A5 Splicing Sites of HIV-1 RNA J. Biol. Chem., July 16, 2004; 279(29): 29963 - 29973. [Abstract] [Full Text] [PDF]

				A. M. Zahler, C. K. Damgaard, J. Kjems, and M. Caputi SC35 and Heterogeneous Nuclear Ribonucleoprotein A/B Proteins Bind to a Juxtaposed Exonic Splicing Enhancer/Exonic Splicing Silencer Element to Regulate HIV-1 tat Exon 2 Splicing J. Biol. Chem., March 12, 2004; 279(11): 10077 - 10084. [Abstract] [Full Text] [PDF]

				K. Verhoef, P. S. Bilodeau, J. L. B. van Wamel, J. Kjems, C. M. Stoltzfus, and B. Berkhout Repair of a Rev-Minus Human Immunodeficiency Virus Type 1 Mutant by Activation of a Cryptic Splice Site J. Virol., April 1, 2001; 75(7): 3495 - 3500. [Abstract] [Full Text]

				M. Graf, A. Bojak, L. Deml, K. Bieler, H. Wolf, and R. Wagner Concerted Action of Multiple cis-Acting Sequences Is Required for Rev Dependence of Late Human Immunodeficiency Virus Type 1 Gene Expression J. Virol., November 15, 2000; 74(22): 10822 - 10826. [Abstract] [Full Text]

				W. G. Fairbrother and L. A. Chasin Human Genomic Sequences That Inhibit Splicing Mol. Cell. Biol., September 15, 2000; 20(18): 6816 - 6825. [Abstract] [Full Text]

				M. B. Rook, C. Bezzina Alshinawi, W.A. Groenewegen, I. C. van Gelder, A. C.G. van Ginneken, H. J. Jongsma, M. M.A.M. Mannens, and A. A.M. Wilde Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome Cardiovasc Res, December 1, 1999; 44(3): 507 - 517. [Abstract] [Full Text] [PDF]

				A. K. Swanson and C. M. Stoltzfus Overlapping Cis Sites Used for Splicing of HIV-1 env/nef and rev mRNAs J. Biol. Chem., December 18, 1998; 273(51): 34551 - 34557. [Abstract] [Full Text] [PDF]

				Z.-h. Si, D. Rauch, and C. M. Stoltzfus The Exon Splicing Silencer in Human Immunodeficiency Virus Type 1 Tat Exon 3 Is Bipartite and Acts Early in Spliceosome Assembly Mol. Cell. Biol., September 1, 1998; 18(9): 5404 - 5413. [Abstract] [Full Text]

				S. Jacquenet, A. Mereau, P. S. Bilodeau, L. Damier, C. M. Stoltzfus, and C. Branlant A Second Exon Splicing Silencer within Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H J. Biol. Chem., October 26, 2001; 276(44): 40464 - 40475. [Abstract] [Full Text] [PDF]